Gonnella N C, Li Y C, Zhang X, Paris C G
Novartis Pharmaceuticals Corp., Summit, NJ 07901, USA.
Bioorg Med Chem. 1997 Dec;5(12):2193-201. doi: 10.1016/s0968-0896(97)00173-9.
The biologically active conformation of a novel, very potent, nonpeptidic stromelysin inhibitor was determined by X-nucleus filtered and multidimensional NMR spectroscopy. This bound conformer was subsequently docked into the stromelysin catalytic domain (SCD) using intermolecular distance constraints derived from NOE data. The complex showed the S1' pocket of stromelysin to be the major site of enzyme-inhibitor interaction with other portions of the inhibitor spanning the S2' and S1 binding sites. Theoretical predictions of SCD-inhibitor binding from molecular modeling studies were consistent with the NMR data. Comparison of modeled enzyme-inhibitor complexes for stromelysin and collagenase revealed an alternate binding mode for the inhibitor in collagenase, suggesting a similar binding interaction might also be possible for stromelysin. The NMR results, however, revealed a single SCD-inhibitor binding mode and provided a structural template for the design of more potent stromelysin inhibitors.
通过X核过滤和多维核磁共振光谱法确定了一种新型、高效、非肽类基质溶解素抑制剂的生物活性构象。随后,利用从NOE数据得出的分子间距离限制,将这种结合构象对接至基质溶解素催化结构域(SCD)中。该复合物显示,基质溶解素的S1'口袋是酶-抑制剂相互作用的主要位点,抑制剂的其他部分跨越S2'和S1结合位点。分子模拟研究对SCD-抑制剂结合的理论预测与核磁共振数据一致。对基质溶解素和胶原酶的模拟酶-抑制剂复合物的比较揭示了抑制剂在胶原酶中的另一种结合模式,这表明基质溶解素可能也存在类似的结合相互作用。然而,核磁共振结果揭示了一种单一的SCD-抑制剂结合模式,并为设计更有效的基质溶解素抑制剂提供了结构模板。